At a glance
ClinicalIndex Comparison RecordN/ACompleted· 112 enrolled
Drug / intervention
ursodeoxycholic acid +1 moredrug
Likely dose
ursodeoxycholic acid 15mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation
Shanghai Jiao Tong University School of Medicine·interventional·Posted Feb 23, 2010·Updated Dec 30, 2010
In Brief
A clinical study evaluating ursodeoxycholic acid and identical-appearing placebo for Liver Transplantation and 2 related conditions. Completed, enrolled 112 participants across 1 site.
Detailed Summary
This study is designed to investigate the possible beneficial effects of UDCA on liver graft recovery early after adult liver transplantation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 2005
Primary CompletionApr 2008
Study CompletionJan 2009
First PostedFeb 2010
TodayJul 2026
First PostedFeb 23, 2010
Enrollment StartMay 1, 2005
Primary CompletionApr 1, 2008
Study CompletionJan 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 16.4 years ago
Interventions
ursodeoxycholic aciddrug
13-15mg/kg/day, 250mg/capsule, given twice per day, within the first 4 weeks after liver transplantation
identical-appearing placebodrug
13-15mg/kg/day, 250mg/capsule, given twice per day, within the first 4 weeks after liver transplantation